References
- MacKinlay S M., Jefferys M. The menopausal syndrome. Br J Prev Soc Med 1974; 28: 108–15
- Ginsburg J, Swinhoe J, O'Reilly B. Cardiovascular responses during the menopausal hot flush. Br J Obstet Gynaecol 1981; 88: 925–30
- Lightman S L., Jacobs H S., Maguire A K. Down-regulation of gonadotropin secretion in postmenopausal women by a superactive LHRH analogue: Lack of effect on menopausal flushing. Br J Obstet Gynaecol 1982; 89: 977–80
- Clayden J R., Bell J W., Pollard P. Menopausal flushing: Double-blind trial of a non-hormonal medication. Br Med J 1974; i: 409–12
- Townsend P T., Whitehead M I., McQueen J, Minardi J, Campbell S. Double-blind studies on the effects of natural estrogens on postmenopausal women: A follow-up report. The Menopause and Postmenopause, N Pasetto, R Paoletti, J L. Ambrus. MTP Press, Lancaster 1980; 75–84
- Iosif C S., Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984; 63: 257–60
- Lyrenäs S, Carlström K, Bäckström T, von Schoultz B. A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17β. Br J Obstet Gynaecol 1981; 88: 181–7
- Helgason S, Damber M-G, von Schoultz B, Stigbrand T. Estrogenic potency or oral replacement therapy estimated by the induction of pregnancy zone protein. Acta Obstet Gynecol Scand 1981; 60: 75–9
- Helgason S. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. Acta Obstet Gynecol Scand 1982, Suppl. 107
- Elkik F, Gompel A, Mercier-Bodard C, Kuttenn F, Guyenne P N., Corvol P, Mauvais-Jarvis P. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women. Am J Obstet Gynecol 1982; 143: 888–92
- Fåhraeus L, Wallentin L. High density lipoprotein sub-fractions during oral and cutaneous administration of 17β-estradiol to menopausal women. J Clin Endocrinol Metab 1983; 56: 797–801
- Englund D. Oestrogen treatment in the menopause. Doctoral thesis at Uppsala University, Sweden 1979
- Hoist J. Percutaneous estrogen therapy. Endometrial response and metabolic effects. Acta Obstet Gynecol Scand 1983, Suppl. 115
- Holst J, Cajander S, Cartström K, Damber M-G, von Schoultz B. A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy. Br J Obstet Gynaecol 1983; 90: 355–60
- Judd H L., Cleary R E., Creasman W T., Figge D C., Kase N, Rosenwaks Z, Tagatz G E. Estrogen replacement therapy. Obstet Gynecol 1981; 58: 267–75
- Hammond C B., Maxson W S. Current status of estrogen therapy for the menopause. Fertil Steril 1982; 37: 5–25